首页|脑梗死应用依达拉奉+血塞通治疗的效果分析

脑梗死应用依达拉奉+血塞通治疗的效果分析

扫码查看
目的 分析脑梗死应用依达拉奉+血塞通治疗的效果。方法 选取2022年1—12月本院收治的88例脑梗死患者为研究对象,并随机分成对照组和观察组,每组44例。其中,对照组采用依达拉奉治疗,观察组采用依达拉奉+血塞通治疗,对比分析两组患者的治疗效果。结果 观察组治疗总有效率高于对照组(P=0。024);观察组NIHSS评分、MRS评分比对照组低,Barthel指数比对照组高(P<0。05)。结论 在脑梗死患者的治疗过程中,采用依达拉奉联合应用血塞通,可显著提升临床疗效,进一步改善神经功能,并有助于提高患者的生活质量。
Effect Analysis of Edaravone+Xuesaitong in Treatment of Cerebral Infarction
Objective To analyze the effect of edaravone+Xuesaitong in treatment of cerebral infarction. Methods The paper chose 88 patients with cerebral infarction (from January 2022 to December 2022),and divided them into the control group and the observation group randomly,with 44 cases in each group. Curative effect of edaravone and edaravone+Xuesaitong was compared and analyzed between two groups. Results Total effective rate of the observation group was 95.45% (42/44),which was higher than 79.55% (35/44) in the control group (P=0.024). The NIHSS scores and MRS scores of the observation group were lower than the control group,the Barthel index was higher than the control group (P<0.05). Conclusion Xuesaitong based on edaravone can achieve excellent clinical effect for patients with cerebral infarction,can optimize neurological function and improve life quality further.

Cerebral infarctionEdaravoneXuesaitongCurative effect

赵晶

展开 >

辽源市人民医院,吉林 辽源 136200

脑梗死 依达拉奉 血塞通 治疗效果

2024

智慧健康

智慧健康

ISSN:
年,卷(期):2024.10(29)